Seven drug regulators, including the EU, UK, and Canada, have warned since 2019 that antidepressant-linked sexual side effects can persist for years after the drug is stopped. The US hasn’t.
Source ↗
👁 0
💬 0
The European Medicines Agency’s safety committee concluded in May 2019 that sexual dysfunction linked to SSRIs and SNRIs, the most widely prescribed classes of antidepressant, can be “long-lasting” and that symptoms “have continued despite discontinuation,” and required member states to update product labelling accordingly within two months. The UK’s product information was updated in line with that EU-wide action the same year. That was a label-level change t
Comments (0)